Yki-Jarvinen et al performed a meta-regression analysis of clinical trials that used either NPH or insulin glargine as treatment options and observed that at equivalent rates of hypoglycemia, insulin glargine was associated with significantly lower A1C levels than NPH insulin [36]. This evidence concerns the gene INS and Hypoglycemia.